Annual public health and economic benefits of seasonal influenza vaccination: a European estimate

2014144 citationsJournal Articlegold Open Access

Authors

E. Préaud · Sanofi (France)

Laure Durand · Sanofi (France)

Bérengère Macabeo · Sanofi (France)

Norbert Farkas · Novartis (Switzerland)

Brigitte Sloesen · GlaxoSmithKline (Belgium)

A.M. Palache · Abbott (Netherlands)

Francis Shupo

Abstract

Full implementation of current influenza vaccination recommendations of 75% vaccination coverage rate (VCR) in Europe by the 2014-2015 influenza season could immediately reduce an important public health and economic burden.

Topics & Keywords

Influenza Virus Research Studies COVID-19 epidemiological studies Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: BMC Public Health

Volume 14, Issue 1, pp. 813-813

DOI: 10.1186/1471-2458-14-813

Field-Weighted Citation Impact: 8.15